Patrick Wood
Stock Analyst at Morgan Stanley
(4.19)
# 806
Out of 4,479 analysts
48
Total ratings
56.25%
Success rate
15.88%
Average return
Main Sectors:
18 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLCO Bausch + Lomb | Upgrades: Overweight | $16 → $18 | $14.66 | +22.78% | 5 | May 6, 2024 | |
| SOLV Solventum | Initiates: Equal-Weight | $70 | $51.60 | +35.66% | 1 | Apr 10, 2024 | |
| EW Edwards Lifesciences | Maintains: Overweight | $95 → $103 | $91.23 | +12.90% | 6 | Mar 21, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $74 → $86 | $76.33 | +12.67% | 5 | Feb 12, 2024 | |
| DXCM DexCom | Maintains: Equal-Weight | $101 → $122 | $112.49 | +8.45% | 4 | Dec 4, 2023 | |
| BSX Boston Scientific | Maintains: Overweight | $58 → $61 | $76.55 | -20.31% | 2 | Dec 4, 2023 | |
| STE STERIS | Maintains: Equal-Weight | $225 → $215 | $218.34 | -1.53% | 3 | Dec 4, 2023 | |
| RBOT Vicarious Surgical | Initiates: Equal-Weight | $18 | $6.56 | +174.39% | 1 | Dec 4, 2023 | |
| GKOS Glaukos | Initiates: Equal-Weight | $65 | $118.98 | -45.37% | 1 | Dec 4, 2023 | |
| STAA STAAR Surgical Company | Initiates: Equal-Weight | $35 | $44.52 | -21.38% | 1 | Dec 4, 2023 | |
| COO The Cooper Companies | Maintains: Equal-Weight | $103 → $89 | $86.51 | +2.59% | 3 | Dec 4, 2023 | |
| BDX Becton, Dickinson and Company | Maintains: Overweight | $310 → $280 | $229.24 | +22.14% | 3 | Dec 4, 2023 | |
| BAX Baxter International | Maintains: Equal-Weight | $45 → $39 | $32.85 | +18.72% | 2 | Dec 4, 2023 | |
| PODD Insulet | Upgrades: Overweight | $185 → $234 | $197.19 | +18.67% | 4 | Dec 4, 2023 | |
| TFX Teleflex | Upgrades: Overweight | n/a | $211.25 | - | 3 | Dec 4, 2023 | |
| RXST RxSight | Initiates: Overweight | $36 | $57.04 | -36.89% | 1 | Dec 4, 2023 | |
| ALC Alcon | Downgrades: Underweight | $65 | $88.79 | -26.79% | 2 | Dec 4, 2023 | |
| DVA DaVita | Upgrades: Buy | n/a | $138.45 | - | 1 | Dec 11, 2017 |
Bausch + Lomb
May 6, 2024
Upgrades: Overweight
Price Target: $16 → $18
Current: $14.66
Upside: +22.78%
Solventum
Apr 10, 2024
Initiates: Equal-Weight
Price Target: $70
Current: $51.60
Upside: +35.66%
Edwards Lifesciences
Mar 21, 2024
Maintains: Overweight
Price Target: $95 → $103
Current: $91.23
Upside: +12.90%
GE HealthCare Technologies
Feb 12, 2024
Maintains: Equal-Weight
Price Target: $74 → $86
Current: $76.33
Upside: +12.67%
DexCom
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $101 → $122
Current: $112.49
Upside: +8.45%
Boston Scientific
Dec 4, 2023
Maintains: Overweight
Price Target: $58 → $61
Current: $76.55
Upside: -20.31%
STERIS
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $225 → $215
Current: $218.34
Upside: -1.53%
Vicarious Surgical
Dec 4, 2023
Initiates: Equal-Weight
Price Target: $18
Current: $6.56
Upside: +174.39%
Glaukos
Dec 4, 2023
Initiates: Equal-Weight
Price Target: $65
Current: $118.98
Upside: -45.37%
STAAR Surgical Company
Dec 4, 2023
Initiates: Equal-Weight
Price Target: $35
Current: $44.52
Upside: -21.38%
The Cooper Companies
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $103 → $89
Current: $86.51
Upside: +2.59%
Becton, Dickinson and Company
Dec 4, 2023
Maintains: Overweight
Price Target: $310 → $280
Current: $229.24
Upside: +22.14%
Baxter International
Dec 4, 2023
Maintains: Equal-Weight
Price Target: $45 → $39
Current: $32.85
Upside: +18.72%
Insulet
Dec 4, 2023
Upgrades: Overweight
Price Target: $185 → $234
Current: $197.19
Upside: +18.67%
Teleflex
Dec 4, 2023
Upgrades: Overweight
Price Target: n/a
Current: $211.25
Upside: -
RxSight
Dec 4, 2023
Initiates: Overweight
Price Target: $36
Current: $57.04
Upside: -36.89%
Alcon
Dec 4, 2023
Downgrades: Underweight
Price Target: $65
Current: $88.79
Upside: -26.79%
DaVita
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $138.45
Upside: -